Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Ariad and U.K.'s NCRI to collaborate on phase III ponatinib trial

Jan. 9, 2013

Labrys Biologics acquires antibody for chronic migraine from Pfizer

Jan. 8, 2013

Philogen enters into worldwide licensing agreement with Pfizer for Dekavil

Jan. 7, 2013

Kyowa Hakko Kirin advances second oncology candidate under agreement with Dicerna

Jan. 7, 2013

Repligen and Pfizer sign worldwide licensing agreement for spinal muscular atrophy

Jan. 4, 2013

PharmaEngine and BeBetter enter oncology collaboration

Jan. 4, 2013

NGM signs agreement with Janssen for novel therapeutics for diabetes

Jan. 4, 2013

Microbiotix enters licensing agreement for MBX-700 and MBX-701

Jan. 4, 2013

Chroma receives milestone payment from GSK for HDAC inhibitor

Jan. 4, 2013

Alize Pharma launches collaborative research program for AZP-531

Jan. 4, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...